← All trials
NCT00809913
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2008
- Primary completion
- May 1, 2013
- Completion date
- Sep 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Leiden UniversityLead sponsor
- Leiden UniversityOverall official - principal investigator
- Leiden UniversityStudy chair
- Bronovo HospitalCollaborator
- Medical Center HaaglandenCollaborator
- Spaarne GasthuisCollaborator
- Rijnland HospitalCollaborator
- Groene Hart ZiekenhuisCollaborator
- Leiden UniversityCollaborator
- Leiden UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.